The novel therapy of tirzepatide peptide represents a exciting advance in the handling of type 2 diabetes. Different to existing drugs, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) and the GIP https://tirzepatidepeptide403939.ageeksblog.com/40376112/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment